What does Apotheek Herne do?

Apotheek Herne is a pharmacy in Pajottegem. Private Limited, started on 15 March 2013, 1 establishment.

What is the address of Apotheek Herne?

The registered office of Apotheek Herne is located at Spoorwegstraat 3, 1540 Pajottegem.

Is Apotheek Herne still active?

Yes. According to the CBE (29 October 2026) Apotheek Herne is active, legal situation “Normale toestand”, started on 15 March 2013.

Is Apotheek Herne registered on Peppol?

Yes, Apotheek Herne is registered on the Peppol network with ID 0208:0523889575.

What is the enterprise number of Apotheek Herne?

The enterprise number of Apotheek Herne is BE0523889575.

When was Apotheek Herne founded?

Apotheek Herne was founded on 15 March 2013.

Who are the directors of Apotheek Herne?

According to the 2026 annual accounts, the directors of Apotheek Herne are: Julie Vanden Daelen, Christophe Bouvry.

Is Apotheek Herne a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 March 2013; 5 annual accounts filed, latest fiscal year 2026; 2 directors known from the annual account.

How much profit did Apotheek Herne make in 2026?

Apotheek Herne posted a profit after taxes of € 62,451 in financial year 2026.

What is the revenue of Apotheek Herne?

As a small company, Apotheek Herne is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 230,519.

How much does an employee at Apotheek Herne earn?

The average wage cost per full-time employee at Apotheek Herne was € 66,000 in 2026: staff costs of € 118,887 for 1.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Herne have?

According to the 2026 annual accounts, Apotheek Herne has 1.8 full-time equivalents (FTE).

Apotheek Herne (Private Limited) - Pajottegem

Dossier Apotheek Herne, printed on 29 October 2026 from databakkes.be/en/0523889575/apotheek-herne. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

Apotheek Herne from Pajottegem, company number BE0523889575, closed financial year 2026 with a result of € 62,451 after tax. For that financial year Apotheek Herne recorded a gross margin of € 230,519 and equity of € 129,946. Compared with financial year 2025, the result moved from € 64,580 to € 62,451. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 26, 2026.

What it is worth Growing

€ 129,946

▲ 93% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 62,451

▼ 3% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 39,729

▲ 57% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 109,946.

People and assets in 2026

Full-time equivalents

1.8

▲ 0.2 vs 2025

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 118,887

▲ 23% vs 2025

€ 66,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,234

▼ 27% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 167,788

▼ 13% vs 2025

€ 25,989 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 5,429

▼ 82% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 3,907

▼ 47% vs 2025

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 161,731 Gross margin 2023: € 161,731 First fiscal year in the series	€ 190,391 Gross margin 2024: € 190,391 ▲ 18% vs 2023 (€ 161,731) Favourable step	€ 227,515 Gross margin 2025: € 227,515 ▲ 19% vs 2024 (€ 190,391) Favourable step	€ 230,519 Gross margin 2026: € 230,519 ▲ 1% vs 2025 (€ 227,515) Favourable step	▲ 1%
Profit after taxes	€ 7,345 Profit after taxes 2023: € 7,345 First fiscal year in the series	€ 40,648 Profit after taxes 2024: € 40,648 ▲ € 33,303 vs 2023 (€ 7,345) Favourable step	€ 64,580 Profit after taxes 2025: € 64,580 ▲ 59% vs 2024 (€ 40,648) Favourable step	€ 62,451 Profit after taxes 2026: € 62,451 ▼ 3% vs 2025 (€ 64,580) Unfavourable step	▼ 3%
Equity	€ -37,732 Equity 2023: € -37,732 First fiscal year in the series	€ 2,915 Equity 2024: € 2,915 ▲ € 40,648 vs 2023 (€ -37,732) Favourable step	€ 67,495 Equity 2025: € 67,495 ▲ € 64,580 vs 2024 (€ 2,915) Favourable step	€ 129,946 Equity 2026: € 129,946 ▲ 93% vs 2025 (€ 67,495) Favourable step	▲ 93%
Total debts	€ 352,151 Total debts 2023: € 352,151 First fiscal year in the series	€ 334,386 Total debts 2024: € 334,386 ▼ 5% vs 2023 (€ 352,151) Favourable step	€ 273,672 Total debts 2025: € 273,672 ▼ 18% vs 2024 (€ 334,386) Favourable step	€ 200,253 Total debts 2026: € 200,253 ▼ 27% vs 2025 (€ 273,672) Favourable step	▼ 27%
Cash	€ 6,156 Cash 2023: € 6,156 First fiscal year in the series	€ 55,002 Cash 2024: € 55,002 ▲ € 48,846 vs 2023 (€ 6,156) Favourable step	€ 25,324 Cash 2025: € 25,324 ▼ 54% vs 2024 (€ 55,002) Unfavourable step	€ 39,729 Cash 2026: € 39,729 ▲ 57% vs 2025 (€ 25,324) Favourable step	▲ 57%
Land & buildings	€ 4,716 Land & buildings 2023: € 4,716 First fiscal year in the series	€ 3,382 Land & buildings 2024: € 3,382 ▼ 28% vs 2023 (€ 4,716) Unchanged	€ 2,667 Land & buildings 2025: € 2,667 ▼ 21% vs 2024 (€ 3,382) Unchanged	€ 1,951 Land & buildings 2026: € 1,951 ▼ 27% vs 2025 (€ 2,667) Unchanged	▼ 27%
Retained profit	€ -57,732 Retained profit 2023: € -57,732 First fiscal year in the series	€ -17,085 Retained profit 2024: € -17,085 ▲ € 40,648 vs 2023 (€ -57,732) Favourable step	€ 47,495 Retained profit 2025: € 47,495 ▲ € 64,580 vs 2024 (€ -17,085) Favourable step	€ 109,946 Retained profit 2026: € 109,946 ▲ 131% vs 2025 (€ 47,495) Favourable step	▲ 131%
Bank debt	€ 269,050 Bank debt 2023: € 269,050 First fiscal year in the series	€ 193,118 Bank debt 2024: € 193,118 ▼ 28% vs 2023 (€ 269,050) Favourable step	€ 193,159 Bank debt 2025: € 193,159 Unchanged (€ 193,118) Unfavourable step	€ 167,788 Bank debt 2026: € 167,788 ▼ 13% vs 2025 (€ 193,159) Favourable step	▼ 13%
Balance sheet total	€ 314,419 Balance sheet total 2023: € 314,419 First fiscal year in the series	€ 337,301 Balance sheet total 2024: € 337,301 ▲ 7% vs 2023 (€ 314,419) Unchanged	€ 341,168 Balance sheet total 2025: € 341,168 ▲ 1% vs 2024 (€ 337,301) Unchanged	€ 330,199 Balance sheet total 2026: € 330,199 ▼ 3% vs 2025 (€ 341,168) Unchanged	▼ 3%
Employees (FTE)	1.2 Employees (FTE) 2023: 1.2 First fiscal year in the series	1.5 Employees (FTE) 2024: 1.5 ▲ 0.3 vs 2023 (1.2) Unchanged	1.6 Employees (FTE) 2025: 1.6 ▲ 0.1 vs 2024 (1.5) Unchanged	1.8 Employees (FTE) 2026: 1.8 ▲ 0.2 vs 2025 (1.6) Unchanged	▲ 0.2

Key figures of Apotheek Herne, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to Apotheek Herne?

What happened at Apotheek Herne in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 26, 2026 New annual accounts for financial year 2026: profit of € 62,451 (▼ 3% vs 2025). Source: NBB ↗
Mar 15, 2013 Start of the company according to the CBE. KBO
Mar 8, 2013 New establishment in Pajottegem. KBO
2013 Julie Vanden Daelen became a director. NBB
2013 Christophe Bouvry became a director. NBB

In short

From € 7,345 profit in 2023 to € 62,451 profit in 2026.

Paid € 57,849 in corporate taxes since 2023.

Best year ever: 2025, with € 64,580 profit.

On average € 128,100 of value added per employee in 2026.

Original PDFs at the National Bank ↗

Management

Julie Vanden Daelen Christophe Bouvry

Apotheek Herne

PARCHIM

Magis-Pharma

isomasters

Behind Apotheek Herne are Julie Vanden Daelen and Christophe Bouvry. Christophe Bouvry is also behind PARCHIM, Magis-Pharma, isomasters and Magis Pharma Group.

Directors

According to the 2026 annual accounts

Julie Vanden Daelen

Director

since 2013

Christophe Bouvry

Director

Also active at: PARCHIM, Magis-Pharma, isomasters, Magis Pharma Group

since 2013

Establishments

Establishment units

Physical locations of this company

Registered office

Spoorwegstraat 3

1540 Pajottegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

GREEN MONKEY

€ 80,132 gross margin · 2026

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0523.889.575

VAT number

BE 0523.889.575

Registered office

Spoorwegstraat 3, 1540 Pajottegem

Names & denominations

Apotheek Herne

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

15 March 2013

Peppol

Active · Active since 13 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Vervaardiging van overige farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Herne

Financials

What happened to Apotheek Herne?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions